It’s Biocon’s day in the sun3 min read . Updated: 17 Jul 2017, 07:56 AM IST
The main reason for the positive shift in Biocon share prices is its steady progression towards launching a biosimilartrastuzumabin Europe and US
It’s been a long winter for Biocon Ltd’s shareholders and they must be happy finally, provided they have held on, of course. The chart shows how Biocon’s shares have done versus the broader markets since its listing in April 2004. They have underperformed the broader markets in the past decade but have seen a decisive move up since 2016. Biocon has also outperformed the BSE Healthcare Index after a long stretch.
Select your Category